Osteonecrose dos maxilares associada ao uso de bifosfonatos: uma revisão de literatura
DOI:
https://doi.org/10.26843/ro_unicid.v28i2.222Palavras-chave:
Odontologia, Difosfonatos, Mandíbula, Maxila, Terapêutica.Resumo
Os Bifosfonatos (BFS) são fármacos antirreabsortivos frequentemente utilizados no tratamento de desordens ósseas e de neoplasias malignas metastáticas. Seu mecanismo de ação consiste na inibição da atividade osteoclástica e angiogênica do tecido ósseo. No entanto, o uso crônico desses medicamentos pode desenvolver a osteonecrose dos maxilares associada aos bifosfonatos (OMAB), principalmente em pacientes submetidos a traumas prévios. O presente trabalho objetiva revisar abordagens terapêuticas para esses pacientes, focando na prevenção e tratamento dessas patologias. A literatura tem apresentado propostas variadas para o tratamento da OMAB, muitas vezes controverso. O tratamento dessas patologias tem se tornado desafiador, uma vez que os protocolos nem sempre são eficientes para controlar tal condição. Assim, previamente à terapêutica com BFS, os profissionais de saúde devem realizar todos os procedimentos necessários para adequação do meio bucal dos pacientes, bem como manter um rigoroso acompanhamento da sua condição bucal. Diante disso, é de fundamental importância a ação multidisciplinar entre médicos e cirurgiões-dentistas no manejo desses pacientes.Downloads
Referências
Fleisch H. Development of bisphosphonates. Breast Cancer Res 2002 4(1):30-4.
Ott SM. Long-term safety of bisphosphonates. J Clin Endocrinol Metab 2005 Mar;90(3):1897-9.
Gegler A, Cherubini K, Figueiredo MAZ, Yurgel LS, Azambuja AA. Bisfosfonatos e osteonecrose maxilar : revisão da literatura e relato de dois casos. Rev Bras Cancerol 2006 52(1):25-31.
Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993 May;91(5):2004-11.
Leite AF, Santos Ogata F, Melo NS, Figueiredo PTS. Imaging findings of bisphosphonate-related osteonecrosis of the jaws : a critical review of the quantitative studies. Int J Dent 2014 1-11.
Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007 Oct;22(10):1479-91
Longo F, Guida A, Aversa C, Pavone E, Di Costanzo G, Ramaglia L, et al. Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent 2014 2014(1):1-7.
Coelho AI, Gomes PS, Fernandes MH. Osteonecrose dos maxilares associada ao uso de bifosfonatos. parte II: inhas de orientação na consulta de medicina dentária. Rev Port Estomatol Med Dentária Cir Maxilofac 2010 2010/07/01;51(3):185-91.
Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004 May;62(5):527-34.
Pereira FA, Pereira JC, Pereira CAA, Carvalho RWF, Antunes AA. Osteonecrose dos maxilares associada a bisfosfonatos. Rev Bras Cir Cabeça Pescoço 2009 out/nov/dez;38(4):283-6.
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007 Mar;65(3):369-76.
Marx RE, Cillo JE, Jr., Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007 Dec;65(12):2397-410.
Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006 Jun;17(6):897-907.
Souza LN, Antunes Souza ACR, Arruda Mari VF, Nogueira Borges AP, Alvarenga RL. Osteonecrose dos maxilares associada ao uso de bisfosfonatos: revisão da literatura e apresentação de um caso clínico. Rev Port Estomatol Med Dentária Cir Maxilofac 2009 50(4):229-36.
Gebara SN, Moubayed H. Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonates. Am J Health Syst Pharm 2009 Sep 1;66(17):1541-7.
Franco S, Miccoli S, Limongelli L, Tempesta A, Favia G, Maiorano E. New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari. Int J Dent 2014 2014(1):1-10.
Sarkarat F, Kalantar Motamedi MH, Jahanbani J, Sepehri D, Kahali R, Nematollahi Z. Platelet-rich plasma in treatment of zoledronic acid-Induced bisphosphonate-related osteonecrosis of the jaws. Trauma Mon 2014 Apr;19(2):e17196.
Nunes V, Lopes B, Lordani RXF, Alves J, Rocha R, Machado W, et al. Uso de bifosfonatos em pacientes com câncer e sua associação com osteonecrose dos ossos maxilares: uma revisão de literatura. Rev Periodontia 2010 set;20(3):20-7.
Sousa FRN, Jardim Junior EG. Osteonecrose associada com o uso dos bifosfonatos. Pesq Bras Odontoped Clin Integr 2008 set/dez;8(3):375-80.
Pastor-Zuazaga D, Garatea-Crelgo J, Martino-Gorbea R, Etayo-Perez A, Sebastian-Lopez C. Osteonecrosis of the jaws and bisphosphonates. Report of three cases. Med Oral Patol Oral Cir Bucal 2006 Jan;11(1):E76-9.
Harper RP, Fung E. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg 2007 Mar;65(3):573- 80.
Sigua-Rodriguez EA, da Costa Ribeiro R, de Brito AC, Alvarez-Pinzon N, Albergaria-Barbosa JR. Bisphosphonaterelated osteonecrosis of the jaw: a review of the literature. Int J Dent 2014 2014(1):1-5.
Scarpa LC, Leite LCM, Lacerda JCT, Arantes DCB. Osteonecrose nos ossos da maxila e mandíbula associada ao uso do bifosfonato de sódio. Rev Bras Pesqui Saude 2010 12(1):86-92.
Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005 Nov;63(11):1567- 75.
Martins MAT, Giglio AD, Martins MD, Pavesi VCS, Lascala CA. Osteonecrose dos maxilares associada ao uso de bisfosfonatos: importante complicação do tratamento oncológico. Rev Bras Hematol Hemoter 2009 fev;31(1):41- 6.
Walter C, Grotz KA, Kunkel M, Al-Nawas B. Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 2007 Feb;15(2):197- 202.
Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003 Jul 31;349(5):457-63.
Hoefert S, Eufinger H. Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Oct;110(4):463-9.
Ficarra G, Beninati F. Bisphosphonaterelated Osteonecrosis of the Jaws: An Update on Clinical, Pathological and Management Aspects. Head Neck Pathol 2007 1(2):132-40.
Passeri LA, Bértolo MB, Abuabara A. Osteonecrose dos maxilares associada ao uso de bisfosfonatos. Rev Bras Reumatol 2011 ago;51(4):404-7.
Gutta R, Louis PJ. Bisphosphonates and osteonecrosis of the jaws: science and rationale. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 Aug;104(2):186-93.
Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2005 Dec;136(12):1658-68.
Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition. J Am Dent Assoc 2005 Dec;136(12):1675-81.
Carvalho A, Mendes RA, Carvalho DCJ. Osteonecrose da mandíbula associada a bifosfonatos intravenosos em doentes oncológicos. Acta Med Port 2008 21(5):505-10.
Silverman SL, Landesberg R. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review. Am J Med 2009 Feb;122(2 Suppl):S33-45.
Campisi G, Fedele S, Fusco V, Pizzo G, Di Fede O, Bedogni A. Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Future Oncol 2014 Feb;10(2):257-75.
Silva AS, Conceição TS, Veloso KMM, Cartágenes MSS. Análise de prontuá- rios de pacientes com câncer de mama em tratamento com bisfosfonatos: fator de risco para manifestações orais e osteonecrose induzida. Rev Soc Bras Clín Méd 2013 jul-set;11(3):242-5.
Khan AA, Sandor GK, Dore E, Morrison AD, Alsahli M, Amin F, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 2008 Jul;35(7):1391-7.
Assael LA. New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg 2004 Feb;62(2):125-6.
Migliorati CA, Armonis BN, NicolatouGalitis O. Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008 Jul;106(1):e18-21.
Santos PSS, Gambirazi LM, Felix VB, Magalhães MHCG. Osteonecrose maxilar em pacientes portadores de doenças neoplásicas sob uso de bisfosfonatos. Rev Bras Hematol Hemoter 2008 dez;30(6):501-4.
Ferreira Junior CD, Casado PL, Barboza ESP. Osteonecrose associada aos bifosfonatos na odontologia. Rev Periodontia 2007 dez;17(24-30):4.
Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005 Dec 1;23(34):8580-7.
Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 Oct;102(4):433-41.
Lopes I, Zenha H, Costa H, Barroso J. Osteonecrose da mandíbula associada ao uso de bifosfonatos: uma patologia secundária grave. Arq Med 2009 23(5):181-5.
Freiberger JJ, Padilla-Burgos R, Chhoeu AH, Kraft KH, Boneta O, Moon RE, et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 2007 Jul;65(7):1321- 7.
Ruggiero SL, Drew SJ. Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 2007 Nov;86(11):1013-21.
Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003 Sep;61(9):1115-7.
Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos I, Antoniadis K, et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 2007 May-Jun;28(3):158-63.
Gomez-Moreno G, Arribas-Fernandez MC, Fernandez-Guerrero M, Boquete- -Castro A, Aguilar-Salvatierra A, Guardia J, et al. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment. Eur Rev Med Pharmacol Sci 2014 18(9):1391- 7.
